Hans Olav Høivik

1.3k total citations
9 papers, 321 citations indexed

About

Hans Olav Høivik is a scholar working on Otorhinolaryngology, Pharmacology and Epidemiology. According to data from OpenAlex, Hans Olav Høivik has authored 9 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Otorhinolaryngology, 3 papers in Pharmacology and 3 papers in Epidemiology. Recurrent topics in Hans Olav Høivik's work include Pneumonia and Respiratory Infections (3 papers), Sinusitis and nasal conditions (3 papers) and Pharmacology and Obesity Treatment (2 papers). Hans Olav Høivik is often cited by papers focused on Pneumonia and Respiratory Infections (3 papers), Sinusitis and nasal conditions (3 papers) and Pharmacology and Obesity Treatment (2 papers). Hans Olav Høivik collaborates with scholars based in Norway, United Kingdom and United States. Hans Olav Høivik's co-authors include Johan Halse, Marianne O’Shea, Alexandra W. C. Einerhand, Ola Gudmundsen, Jean‐Michel Gaullier, Kjetil Høye, E. Lingaas, Rolf Haye, Colleen Twomey and Andrew J. T. Kirkham and has published in prestigious journals such as International Journal of Obesity, British Journal Of Nutrition and Cephalalgia.

In The Last Decade

Hans Olav Høivik

9 papers receiving 305 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hans Olav Høivik Norway 6 145 126 64 51 49 9 321
AJ Sinclair United Kingdom 10 137 0.9× 107 0.8× 71 1.1× 36 0.7× 49 1.0× 21 395
Sarah Torri United States 10 158 1.1× 92 0.7× 85 1.3× 14 0.3× 42 0.9× 12 439
Barbara Wendland Canada 7 106 0.7× 91 0.7× 31 0.5× 74 1.5× 64 1.3× 9 381
P. Ashby United Kingdom 11 137 0.9× 179 1.4× 20 0.3× 58 1.1× 85 1.7× 12 528
Zuzana Paduchová Slovakia 11 63 0.4× 92 0.7× 22 0.3× 22 0.4× 92 1.9× 16 304
Pedro S.P. Huot Canada 14 107 0.7× 129 1.0× 15 0.2× 32 0.6× 128 2.6× 20 463
M.J. Martínez-Ramírez Spain 11 69 0.5× 158 1.3× 39 0.6× 41 0.8× 198 4.0× 24 427
David G. Guy United States 7 142 1.0× 172 1.4× 17 0.3× 34 0.7× 136 2.8× 9 541
M Šustrová Slovakia 10 46 0.3× 40 0.3× 39 0.6× 34 0.7× 78 1.6× 15 349
Gisella Mutungi United States 9 134 0.9× 135 1.1× 31 0.5× 63 1.2× 42 0.9× 11 429

Countries citing papers authored by Hans Olav Høivik

Since Specialization
Citations

This map shows the geographic impact of Hans Olav Høivik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Olav Høivik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Olav Høivik more than expected).

Fields of papers citing papers by Hans Olav Høivik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans Olav Høivik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Olav Høivik. The network helps show where Hans Olav Høivik may publish in the future.

Co-authorship network of co-authors of Hans Olav Høivik

This figure shows the co-authorship network connecting the top 25 collaborators of Hans Olav Høivik. A scholar is included among the top collaborators of Hans Olav Høivik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans Olav Høivik. Hans Olav Høivik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Høivik, Hans Olav, Bart Laurijssens, Lutz Harnisch, et al.. (2010). Lack of efficacy of the selective iNOS inhibitor GW274150 in prophylaxis of migraine headache. Cephalalgia. 30(12). 1458–1467. 78 indexed citations
2.
Gaullier, Jean‐Michel, Johan Halse, Hans Olav Høivik, et al.. (2007). Six months supplementation with conjugated linoleic acid induces regional-specific fat mass decreases in overweight and obese. British Journal Of Nutrition. 97(3). 550–560. 142 indexed citations
3.
Halse, Johan, Hans Olav Høivik, Karsten Kristiansen, et al.. (2006). The effect of 6 months supplementation with conjugated linoleic acid on insulin resistance in overweight and obese. International Journal of Obesity. 31(7). 1148–1154. 46 indexed citations
4.
Haye, Rolf, et al.. (1998). Azithromycin versus placebo in acute infectious rhinitis with clinical symptoms but without radiological signs of maxillary sinusitis. European Journal of Clinical Microbiology & Infectious Diseases. 17(5). 309–312. 27 indexed citations
5.
Lingaas, E., et al.. (1998). Azithromycin versus Placebo in Acute Infectious Rhinitis with Clinical Symptoms but without Radiological Signs of Maxillary Sinusitis. European Journal of Clinical Microbiology & Infectious Diseases. 17(5). 309–312. 2 indexed citations
6.
Haye, Rolf, et al.. (1996). Efficacy and safety of azithromycin versus phenoxymethylpenicillin in the treatment of acute maxillary sinusitis. European Journal of Clinical Microbiology & Infectious Diseases. 15(11). 849–853. 13 indexed citations
7.
Høivik, Hans Olav, et al.. (1986). [Combined analgesics in myalgia of the neck. A double-blind comparison of paracetamol and orphenadrine (Norgesic) and paracetamol and codeine (Paralgin forte) in general practice].. PubMed. 106(2). 126–8. 2 indexed citations
8.
Høivik, Hans Olav, et al.. (1983). [Effect of orphenadrine/paracetamol combination tablets (Norgesic) on myalgia. A double-blind comparative study using a placebo in general practice].. PubMed. 103(6). 597–9. 3 indexed citations
9.
Høivik, Hans Olav, et al.. (1983). Effect of a combination of orphenadrine/paracetamol tablets (‘Norgesic’) on myalgia: A double-blind comparison with placebo in general practice. Current Medical Research and Opinion. 8(8). 531–535. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by AJ Sinclair Breakdown of academic impact, for papers by Sarah Torri Breakdown of academic impact, for papers by Barbara Wendland Breakdown of academic impact, for papers by P. Ashby Breakdown of academic impact, for papers by Zuzana Paduchová Breakdown of academic impact, for papers by Pedro S.P. Huot Breakdown of academic impact, for papers by M.J. Martínez-Ramírez Breakdown of academic impact, for papers by David G. Guy Breakdown of academic impact, for papers by M Šustrová Breakdown of academic impact, for papers by Gisella Mutungi
Rankless by CCL
2026